Chronic Insomnia Market Expected to Thrive at a CAGR of 7.29% for the Study Period 2018-2030 in the 7MM, Estimates DelveInsight - Seite 2

Various studies worldwide have shown the prevalence of insomnia in 10–30% of the population, some even as high as 50–60%. As per DelveInsight's Chronic Insomnia epidemiological analysis, Chronic Insomnia is slightly more prevalent among females than males. 

The Chronic Insomnia market report offers historical and forecasted epidemiological analysis during the study period 2018-30 in the 7MM segmented into:

• Chronic Insomnia Prevalent Cases
• Chronic Insomnia Diagnosed Prevalent Cases 
• Gender-specific Chronic Insomnia Cases 
• Age-specific Chronic Insomnia Cases 

For more insights, visit Chronic Insomnia Epidemiological Analysis and Forecast 

Chronic Insomnia Market 

The primary goal of the Chronic Insomnia market is to improve sleeping habits and alleviate symptoms such as distress and dysfunction. It can be managed with the help of psychological therapy, pharmacologic therapy, or a combination of both. 

Psychological therapy options present in the Chronic Insomnia market include cognitive behavioral therapy for insomnia (CBT-I), multicomponent behavioral therapy or brief behavioral therapy (BBT) for insomnia, and other interventions, such as stimulus control, relaxation strategies, and sleep restriction. 

Benzodiazepines are frequently prescribed to treat insomnia. Five benzodiazepines (estazolam, flurazepam, quazepam, temazepam, and triazolam) are in market as the FDA-approved medications for insomnia management. Non-benzodiazepine hypnotics include zopiclone, zolpidem, and zaleplon. Orexin receptor antagonists, including Dayvigo and Belsomra, recently gained popularity in the Chronic Insomnia market therapy. 

Reach out to us @ Chronic Insomnia Market Landscape, Growth, Drivers and Barriers 

However, several limitations exist in the present Chronic Insomnia market. Lack of in-depth clinical training in current medical curricula has resulted in delayed or misdiagnosed and improper treatment plans for patients. An increased understanding and screening of insomnia disorder by health care professionals could result in broader public knowledge of insomnia disorder and sleep health.